Table 1.
Alcohol Intake | Pattern Recognition | ||||
---|---|---|---|---|---|
Species | Study | Cell Type/Organ | Major Finding | Reference | |
acute | human | in vitro | monocytes | ↓ TLR8- and TLR4-mediated TNFα synthesis (mRNA, protein) | [26,27] |
in vitro | monocytes | ↓ TLR4-dependent NFκB activation | [27] | ||
mouse | in vivo | liver | ↓ TLR4 gene expression | [21] | |
in vivo | intestine | ↓ TLR4-mediated cytokine production (sepsis model) | [23] | ||
in vitro | microglial cells | ↑ TLR4 and TLR2 mRNA at 1 h ↓ TLR4 and TLR2 mRNA at 3 h |
[24] | ||
in vivo | macrophages | ↓ TLR2, TLR4 and TLR9 induced inflammatory response mediated by p38 and ERK1/2 | [25] | ||
rat | in vivo | intestine | ↓ TLR4 sensitivity to ligands (LPS) | [22] | |
chronic | mouse | in vivo | liver macrophages | ↑ TLR4 protein expression | [29] |
in vivo | liver | ↑ all TLR mRNAs except TLR3 and TLR5 (TLR10 and TLR11 not tested) ↓ antibiotics effectiveness toward TLR mRNA expression ↓ TNFα protein level by NADPH oxidase inhibition |
[29] | ||
NF-κB signaling | |||||
acute | human | in vitro | monocytes | ↑ p50 translocation to the nucleus ↓ cytokine levels = p65/RelA |
[54,55] |
in vitro | FEMX-I melanoma cells | ↑ NF-κB activation | [56] | ||
in vitro | monocytes | ↓ NF-κB activity independently on IκB α degradation | [57] | ||
in vitro | monocytes | ↑ IRAK-M ↓ IκB α kinase activity, NF-κB DNA binding, and NF-κB driven cellular responses |
[63] | ||
mouse | in vitro | alveolar type 2 epithelial cells | ↓ CXCL5 expression ↓ p65 phosphorylation (following LPS and TNFα exposure) |
[60] | |
in vivo | kupffer cells | ↓ IRAK-1 and LPS-mediated activation of NF-κB at 1 h in ↑ IRAK-1 and LPS-induced NF-κB activity at 24 h |
[64] | ||
rat | in vitro | kupffer cells | ↓ LPS-induced NF-κB activation ↓ TNFα mRNA and TNFα secretion |
[53] | |
in vivo | peritoneal macrophages | ↓ NF-κB activation = LPS-induced p65 translocation | [59] | ||
chronic | human | in vitro | monocytes | ↓IRAK-M activity ↑IRAK-1 and IKK kinase levels, NF-κB DNA binding and responses ↑ ERK activation |
[63] |
mouse | in vivo | kupffer cells, leukocytes, liver |
↑NF-κB phosphorylation ↑ NF-κB activation |
[61,62] | |
Bacterial clearance | |||||
acute | human | healthy volunteers | blood | ↑ serum endotoxin ↑ 16 S rDNA levels |
[83] |
mouse | in vivo | peritoneal cavity + spleen; intestinal barrier, blood |
↓ bacterial clearance ↑ overgrowth of bacteria, and ↑ translocation of pathogens into the bloodstream |
[23,90] | |
rat | in vivo | bacteria numbers in the lungs, blood | delayed lung neutrophil recruitment ↑ elevated bacterial burden, systemic dissemination to spleen, blood, and liver |
[81] | |
chronic | human | ↑ bacterial infections | [85] | ||
rats | in vivo | systemic, gut mucosa | ↑ endotoxemia | [87] | |
Cytokines | |||||
acute | human | in vitro | lung epithelial cells | ↓ IL-8 and IL-6 release | [127,128] |
in vitro | monocytes | ↓ TNFα release and gene expression ↑ IL-10 |
[27,63] | ||
healthy volunteers | blood | ↑ TNFα after 20 minutes, followed by ↓ IL-1β after 2-5 hours | [134] | ||
trauma patients | blood | ↓ IL-6 ↑ TNFα after 20 minutes, followed by ↓ IL-1β after 2-5 hours |
[137,138] | ||
mouse | in vivo | blood | ↓ CXCL9, IL-6 and IL-12 ↑ IL-10 |
[129] | |
in vivo | peritoneal lavage fluid | ↓ IL-15, TNFα, IL-9, IL-1β & IL-1α, IL-13, IL-17, and IL-6 ↑ IL-10 and MIP-2 |
[23] | ||
in vivo | blood, lung | ↑ IL-6 and TNFα ↑ IL-6 |
[139,140] | ||
in vivo | ileal tissue | ↑ IL-6, IL-1β and IL-18 protein | [141,142] | ||
chronic | human | in vitro | monocytes | ↑ TNFα = IL-10 protein level | [28,63] |
alcoholic liver disease | blood | ↑ TNFα, IL-6 and IL-1 | [131] | ||
acute alcoholic hepatitis | blood | ↑ IL-8, IL-4, and IFNγ | [132] | ||
mouse | in vivo | liver | ↑ mRNA expression of TNFα, IL-6 and IL-10 ↑ TNFα level |
[29,130] | |
rat | in vivo | blood | ↑ IL-1, IL-10 and TNFα | [147] | |
in vivo | blood | = TNFα, IL-10, IL-6 or CXCL1 without inflammatory trigger, but ↑of IL-6 and TNF upon stimulation | [148] | ||
in vivo | blood | ↑ IL-6, MCP-1 and TNFα | [61] | ||
Cellular responses | |||||
acute | human | precarious ill patients | blood | ↓ CRP, circulating neutrophils and neutrophilic CD64 | [200] |
mouse | in vivo | wounds | ↓ MPO and neutrophilic infiltration | [172] | |
in vivo | leukocytes | ↓ cellular recruitment ↓ adhesion molecules ICAM-1, VCAM1, and E-selectin ↓ chemokines like CXCL8, MCP-1 and RANTES |
[201] | ||
in vivo | lung neutrophils | ↓ recruitment | [207] | ||
rat | in vivo | isolated PMN | ↑ chemotaxis and superoxide release ↓ ingestion and intracellular killing |
[175] | |
in vivo | isolated PMN | ↓ reduced phagocytosis of virulent K. pneumoniae | [176] | ||
chronic | mouse | in vivo | brain tissue, microglia | ↑ microglia activation | [180] |
in vitro | microglia | ↑ mitochondrial ROS production | [180] | ||
in vivo | alveolar macrophages | ↓ cellular functions e.g. phagocytosis | [183,184] | ||
in vivo | liver | ↑ E-selectin expression = expression of P-selectin, ICAM-1, and VCAM1 | [184] | ||
rat | in vivo | isolated PMN | ↓ ROS | [174] | |
in vivo | systemic, gut mucosa | ↑ ROS | [87] | ||
in vivo | liver | modulation of different steps of neutrophil infiltration | [186] | ||
in vivo | isolated PMN | ↑ CD18 expression | [187] | ||
Others | |||||
acute | human | in vitro | neuroblastoma cells | ↑ HMGB1 expression and release | [91] |
in vitro | macrophages | ↑ IL-1β and inflammasome activation | [145] | ||
mice | in vivo | brain | ↑ P2X7R in alcohol sensitive brain regions | [92] |